VEGF and VEGFR-2 (KDR) internalization is required for endothelial recovery during wound healing

被引:121
作者
Rosa Santos, Susana Constantino
Miguel, Claudia
Domingues, Ines
Calado, Angelo
Zhu, Zhenping
Wu, Yan
Dias, Sergio [1 ]
机构
[1] IPOFG, CIPM, CROL, SA,Angiogenesis Lab, Lisbon, Portugal
[2] Fac Med Lisbon, Unidade Biopatol Vasc, Inst Biopatol Quim, Inst Mol Med, Lisbon, Portugal
[3] IGC, Oeiras, Portugal
[4] ImClone Syst, New York, NY USA
[5] Inst Mol Med, Lisbon, Portugal
关键词
VEGF; KDR; FLT-1; endothelial; transport; wound healing;
D O I
10.1016/j.yexcr.2007.02.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Vascular endothelial growth factor (VEGF) receptor activation regulates endothelial cell (EC) survival, migration and proliferation. Recently, it was suggested the cross-talk between the VEGF receptors-1 (FLT-1) and -2 (KDR) modulated several of these functions, but the detailed molecular basis for such interactions remained unexplained. Here we demonstrate for the first time that VEGF stimulation of EC monolayers induced a rapid FLT-1-mediated internalization of KDR to the nucleus, via microtubules and the endocytic pathway, internalization which required the activation of PI 3-kinase/AKT. KDR deletion mutants were generated in several tyrosine residues; in these, VEGF-induced KDR internalization was impaired, demonstrating this process required activation (phosphorylation) of the receptor. Furthermore, we demonstrate that in vitro wounding of EC monolayers leads to a rapid and transient internalization of VEGF+KDR to the nucleus, which is essential for monolayer recovery. Notably, FLT-1 blockade impedes VEGF and KDR activation and internalization, blocking endothelial monolayer recovery. Our data reveal a previously unrecognized mechanism induced by VEGF on EC, which regulates EC recovery following wounding, and as such indicate novel targets for therapeutic intervention. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1561 / 1574
页数:14
相关论文
共 23 条
[1]   Role of PIGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 [J].
Autiero, M ;
Waltenberger, J ;
Communi, D ;
Kranz, A ;
Moons, L ;
Lambrechts, D ;
Kroll, J ;
Plaisance, S ;
De Mol, M ;
Bono, F ;
Kliche, S ;
Fellbrich, G ;
Ballmer-Hofer, K ;
Maglione, D ;
Mayr-Beyrle, U ;
Dewerchin, M ;
Dombrowski, S ;
Stanimirovic, D ;
Van Hummelen, P ;
Dehio, C ;
Hicklin, DJ ;
Persico, G ;
Herbert, JM ;
Communi, D ;
Shibuya, M ;
Collen, D ;
Conway, EM ;
Carmeliet, P .
NATURE MEDICINE, 2003, 9 (07) :936-943
[2]  
Belotti D, 1996, CLIN CANCER RES, V2, P1843
[3]  
Cascinu S, 2000, CLIN CANCER RES, V6, P2803
[4]   Vascular endothelial growth factor and soluble Tie-2 receptor in colorectal cancer: associations with disease recurrence [J].
Chin, KF ;
Greenman, J ;
Reusch, P ;
Gardiner, E ;
Marme, D ;
Monson, JRT .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (06) :497-505
[5]   Vascular endothelial growth factor-dependent down-regulation of Flk-1/KDR involves Cbl-mediated ubiquitination -: Consequences on nitric oxide production from endothelial cells [J].
Duval, M ;
Bédard-Goulet, S ;
Delisle, C ;
Gratton, JP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (22) :20091-20097
[6]  
DVORAK HF, 1995, AM J PATHOL, V146, P1029
[7]   Role of vascular endothelial growth factor in Physiologic and Pathologic angiogenesis: Therapeutic implications [J].
Ferrara, N .
SEMINARS IN ONCOLOGY, 2002, 29 (06) :10-14
[8]  
Folkman J, 1997, EXS, V79, P1
[9]  
Hormbrey E, 2003, CLIN CANCER RES, V9, P4332
[10]   INTERNALIZATION OF ACTIVATED PLATELET-DERIVED GROWTH-FACTOR RECEPTOR-PHOSPHATIDYLINOSITOL-3' KINASE COMPLEXES - POTENTIAL INTERACTIONS WITH THE MICROTUBULE CYTOSKELETON [J].
KAPELLER, R ;
CHAKRABARTI, R ;
CANTLEY, L ;
FAY, F ;
CORVERA, S .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (10) :6052-6063